Adel Ferrum Ars 30ch 10ml

53

The homoeopathic medication ADEL Ferrum Arsnicosum Dilution is effective in treating a variety of skin conditions like eczema and dry skin, as well as spleen and enlarged liver, anaemia, undigested stool, constipation, inflammation of female genitals, and paralysis of the rectum. It is also helpful in treating spleen and enlarged liver, anaemia, undigested stool, fever, and an increase in urine protein.

Important elements:

  • Arsenic and Ferrum

Major advantages:

  • Relief from coughing, catarrhal headaches, paroxysmal temple and vertex pain, and head heaviness is provided by this medication.
  • relieves pain in the eyes, paralysis of the optic nerve, redness, swelling of the eyes and eyelids, and vision loss
  • alleviates pain and inflammation in the bowels, flatulence, and abdominal muscles
  • reduces swollen liver and spleen, as well as the pain associated with hypochondria.
  • alleviates flatus, anus itching, diarrhea, and constipation
  • reduces burning, discomfort, and rectum paralysis during and after bowel movements
  • relieves kidney pain, urethral burning, involuntary urination, and bladder pain
  • alleviates chest pain and treats jitters, aches, and oppression.
  • reduces inflammation and bronchial spasms, as well as lung hemorrhage
  • relieves heaviness, heaviness, and weakness in the thighs, calves, hands, and feet.
  • Efficacious uterine bleeding and uterine discomfort

Useful instructions

  • Take three to five drops every two to three hours, or as your doctor may instruct.

Observations on safety

  • Before using, closely examine the label.
  • Limit your intake to that which is advised.
  • Keep children’s reach away from this.
  • Keep your items somewhere dry and cool.

Important Information: Use only after speaking to a licensed medical professional.

Attributes
BrandAdel Pekana
Container TypeGlass Bottle
Shelf Life5 Years From Date Of Manufacturing
Remedy TypeHomeopathic
Country of OriginGermany
Homeo FormsDilution
Potency30 CH / 30CH
Price₹ 130

Comments are closed.